Recombinant Human C1 Inhibitor (rHC1INH) Is Efficacious and Well Tolerated As Prophylaxis for Prevention of Hereditary Angioedema (HAE) Attacks: A Randomized, Phase 2 Trial
Authors:
- William H. YangWYWilliam H. Yang
- H.H. LiHLH.H. Li
- Chevy ChaseCCChevy Chase
- D. MoldovanDMD. Moldovan
- V. Grivcheva-PanovskaVGV. Grivcheva-Panovska
- J.R. HarperJHJ.R. Harper
- A. RelanARA. Relan
- Marc A. RiedlMRMarc A. Riedl
- 1 February 2017
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (2) , AB231